G. Redekop et al., Endovascular occlusion of basilar bifurcation aneurysms with electrolytically detachable coils, CAN J NEUR, 26(3), 1999, pp. 172-181
Object: To describe the clinical and angiographic results of endovascular o
cclusion of basilar bifurcation aneurysms with electrolytically detachable
coils, and to identify factors which should be considered in deciding upon
surgical or endovascular treatment. Methods: We report our experience with
40 patients in whom occlusion of basilar bifurcation aneurysms with electro
lytically detachable coils was attempted. All patients underwent superselec
tive angiography and attempted embolization with Guglielmi detachable coils
(GDCs). Angiographic and clinical results mere prospectively recorded. Twe
nty-eight aneurysms presented with subarachnoid hemorrhage (SAH), 2 were sy
mptomatic and 10 were incidental. Results: Coils were not placed in 10 pati
ents (25%) because of unfavorable anatomy. Complete aneurysm occlusion was
achieved at the time of the initial procedure in 13 (32.5%), small neck rem
nants were present in 13 (32.5%), and in 4 (10.0%) there was obvious residu
al contrast filling of the aneurysm body. Of 23 patients successfully coile
d after SAH, 20 were Grade 1 to 3 and 3 were grade 4 or 5 at the time of tr
eatment. Eighteen (78%) made a good recovery. Procedural mortality was 2.5%
and permanent morbidity was 7.5%. There were no permanent complications in
patients with unruptured aneurysms. Complete aneurysm occlusion was possib
le in 10 (56%) of 18 aneurysms with small necks and 3 (14%) of 22 with larg
e necks. Follow-up angiography in 25 of 28 surviving patients (mean, 12 mon
ths) demonstrated stability of all completely occluded aneurysms. Incomplet
ely coiled aneurysms had variable results on follow-up angiograms: 15.4% im
proved, 69.2% worsened, and 15.4% were stable. No aneurysm bled after treat
ment during clinical follow-up averaging 22 months. Conclusions: Endovascul
ar treatment of basilar bifurcation aneurysms appears to prevent early aneu
rysm rebleeding with acceptable rates of morbidity and mortality, but long-
term follow-up is required.